Compound details
Hordatine A
| Compound ID | CDAMM01987 |
|---|---|
| Common name | Hordatine A | IUPAC name | N-[4-(diaminomethylideneamino)butyl]-5-[3-[4-(diaminomethylideneamino)butylamino]-3-oxoprop-1-enyl]-2-(4-hydroxyphenyl)-2,3-dihydro-1-benzofuran-3-carboxamide |
| Molecular formula | C28H38N8O4 |
| Retention time | 19.56 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 551.31 | Theoretical mz | 551.309 |
| Error | 1.49 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.2578 |
| Inchi key | KVYNYRIOAYQBFK-WSHNJGOUNA-N |
|---|---|
| Smiles | O=C(C=CC1=CC=C2OC(C3=CC=C(O)C=C3)C(C(=O)NCCCCNC(=N)N)C2=C1)NCCCCNC(=N)N |
| Superclass | Phenylpropanoids and polyketides |
| Class | 2-arylbenzofuran flavonoids |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| Q8WUI4 | HDAC7 | Histone deacetylase 7 | T98698 | SEA |
| Q9UKV0 | HDAC9 | Histone deacetylase 9 | T03687 | SEA |
| P35462 | DRD3 | Dopamine D3 receptor | T02551 | SEA |
| P43116 | PTGER2 | Prostanoid EP2 receptor | T38529 | SEA |
| P13500 | CCL2 | C-C motif chemokine 2 | T89988 | SEA |
| P06737 | PYGL | Liver glycogen phosphorylase | T19184 | SEA |
| P61073 | CXCR4 | C-X-C chemokine receptor type 4 | T96079 | SEA |
| P33032 | MC5R | Melanocortin receptor 5 | T95302 | SEA |
| P42263 | GRIA3 | Glutamate receptor AMPA 3 | T62391 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T02551 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | P35462 | DRD3 |
| T02551 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P35462 | DRD3 |
| T38529 | DI0003 | Abortion | [ICD-11: JA00] | P43116 | PTGER2 |
| T38529 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | P43116 | PTGER2 |
| T38529 | DI0121 | Diabetic foot ulcer | [ICD-11: BD54] | P43116 | PTGER2 |
| T38529 | DI0166 | Glaucoma | [ICD-11: 9C61] | P43116 | PTGER2 |
| T38529 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P43116 | PTGER2 |
| T38529 | DI0378 | Sexual dysfunction | [ICD-11: HA00-HA01] | P43116 | PTGER2 |
| T38529 | DI0413 | Transplant rejection | [ICD-11: NE84] | P43116 | PTGER2 |
| T89988 | DI0083 | Chronic kidney disease | [ICD-11: GB61] | P13500 | CCL2 |
| T89988 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P13500 | CCL2 |
| T89988 | DI0087 | Chronic pain | [ICD-11: MG30] | P13500 | CCL2 |
| T89988 | DI0184 | Human immunodeficiency virus disease | [ICD-11: 1C60-1C62] | P13500 | CCL2 |
| T89988 | DI0252 | Melanoma | [ICD-11: 2C30] | P13500 | CCL2 |
| T89988 | DI0262 | Metastatic tumour | [ICD-11: 2D50-2E2Z] | P13500 | CCL2 |
| T89988 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P13500 | CCL2 |
| T89988 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | P13500 | CCL2 |
| T89988 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P13500 | CCL2 |
| T89988 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P13500 | CCL2 |
| T96079 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P61073 | CXCR4 |
| T96079 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | P61073 | CXCR4 |
| T95302 | DI0005 | Acne vulgaris | [ICD-11: ED80] | P33032 | MC5R |
| T95302 | DI0371 | Sebaceous gland disorder | [ICD-11: ED91] | P33032 | MC5R |
| T62391 | DI0298 | Neuropathy | [ICD-11: 8C0Z] | P42263 | GRIA3 |